Rhythm Biosciences LimitedASX: RHY

Quarterly Activities Report and Appendix 4C

Jul 29, 2026 at 6:33 PM EDT · Issued by Rhythm Biosciences Limited via ASX

Filed with ASX · Jul 29, 2026 at 6:33 PM EDT

On 6ix: 6ix.com/news/quarterly-activities-report-and-appendix-4c-138

ASX Announcement 30 th July 2026 Revision: one Date Issued: 00/00/ Rhythm Biosciences Ltd ACN 619 459 335 ASX: RHY www.rhythmbio.com Australian Registered Address Bio21 Molecular Science & Biotechnology Institute 30 Flemington Road Parkville VIC 3010 Australia ...

View Attachment

6ix hasn’t read this filing yet.

Rhythm Biosciences Limited on 6ix

Story so far

Half-Year Financial Report and Appendix 4DFeb 18, 2026
Appendix 4C and Market UpdateOct 29, 2025
Appendix 4EAug 29, 2025

Earlier from Rhythm Biosciences

Response to ASX Query LetterApr 14
First ColoSTAT Clinical Test SaleMar 10
NATA Accredits ColoSTAT Clinical Testing ServiceMar 8
RHY Executes SE Asian Genetype Distribution AgreementMar 3
Exercise of RHYO Options underwritten for $4.5m to $6.0mFeb 24

Later from Rhythm Biosciences

Bioshares 2026 PresentationAug 5
ColoSTAT Commercial Rollout UpdateAug 19
Notification of cessation of securities - RHYAug 20
Appointment of Non-Executive DirectorsAug 25
FY26 Appendix 4E & Audited Financial ReportAug 27

All Rhythm Biosciences news releases

Follow Rhythm Biosciences into a list and get an email when it puts out news.

Follow Rhythm Biosciences